Literature DB >> 6187084

The lack of correlation between inhibition of aggregation and cAMP levels with canine platelets.

W H Tsien, S P Sass, H Sheppard.   

Abstract

Arachidonic acid (AA) induced aggregation of canine platelets can be inhibited by various phosphodiesterase inhibitors (PDIs) with the order of potency IBMX greater than or equal to papaverine greater than Ro 20-1724 greater than theophylline. With aggregation induced by AA plus epinephrine (EPI), only IBMX and papaverine inhibited at 100 microM. None of these PDIs affected the basal cAMP levels but all potentiated the PGE1-stimulated cAMP production, with the order of potency being Ro 20-1724 greater than papaverine greater than IBMX greater than theophylline. PGE1 at 1 microM caused a sharp increase in cAMP and complete inhibition of platelet aggregation induced by AA plus EPI. However, when EPI was added before PGE1, there was no elevation of cAMP yet inhibition of aggregation still occurred. Our results indicated that inhibition of platelet aggregation does not require a measurable increase in cAMP.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6187084     DOI: 10.1016/0049-3848(82)90167-0

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

1.  Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities.

Authors:  G Archipoff; A Beretz; K Bartha; C Brisson; C de la Salle; C Froget-Léon; C Klein-Soyer; J P Cazenave
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

2.  Effects of pentoxifylline on canine platelet aggregation.

Authors:  John M Thomason; Todd M Archer; Robert W Wills; Andrew J Mackin
Journal:  Vet Med Sci       Date:  2021-08-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.